PERSONALIZED MEDICINE
Explore breakthroughs in personalized medicine, biohacking, and genetically customized pharma driven by genetic research. Discover how scientists are using DNA to customize medicines of all kinds. Even food & beverage are being infused with DNA-altering formulas.
Personalized medicine is a core GMG category because it represents genomics’ most immediate and investible pathway to reshaping healthcare economics.
Explore how future pharma will personalize medicine—customizing drugs by mood and genetics. Discover opportunities, challenges, expert views, and real-world examples.
Who should control the power of CRISPR? This article explores global legal frameworks, ethical debates, and regulatory battles shaping the future of gene editing.
DNA may be the blueprint of life, but proteins interpret it. Understanding protein signaling networks is key to genomics, disease, and precision medicine
A new genetic study reveals a “ghost lineage” of ancient humans in Colombia who vanished 2,000 years ago, leaving no modern descendants behind.
A futurist analysis of antimicrobial resistance using genomic surveillance as the real-world defense against rapidly evolving bacterial threats.
Explore how future pharma will personalize medicine—customizing drugs by mood and genetics. Discover opportunities, challenges, expert views, and real-world examples.
Who should control the power of CRISPR? This article explores global legal frameworks, ethical debates, and regulatory battles shaping the future of gene editing.
DNA-based data storage could someday hold not just information, but even questions of identity — are we heading toward downloadable souls?
CRISPR therapies like Casgevy offer cures for genetic diseases — but who gets access? An urgent call for equity in the age of gene editing.
Should humans be genetically engineered to survive Mars? Explore the real science and bioethics behind CRISPR and NASA’s quest for off-world adaptation.
Playful exploration of nutrigenomics, where food talks to your DNA and the future of eating could be driven by epigenetics and gene-based diets.
AI is helping redesign zinc fingers and other gene editors to avoid immune rejection — opening new doors for safer gene therapies.
Ghosts in the Genome explores the scientific and ethical complexities of germline gene editing—examining current capabilities, limitations, and the ongoing debate over genetic modifications that affect future generations.
Explore how future pharma will personalize medicine—customizing drugs by mood and genetics. Discover opportunities, challenges, expert views, and real-world examples.
The line between what we eat and how we heal is coming closer than ever. With chronic diseases on the rise and more people seeking foods that do more than just fill them up, the future of snacks and meals is evolving.
Consumer gene testing makes personal DNA data a valuable asset. Explore the legal and ethical risks, ownership rights, data breaches, and how your genome can be sold or shared—often without your clear consent.